Key steps that trigger breakdown of normal cell behavior which are responsible for causing tumors to grow and spread through the body have been identified by scientists.
The researchers discovered that a protein called Exo70 has a split personality, with one form keeping cells under tight control and another contributing to the ability of tumors to invade distant parts of the body.
World Cancer Death Clock
World Cancer Death Clock is a dynamic calculator that constantly updates the number of people in the world dying due to various cancers.
Advertisement
The study points to new possibilities for diagnosing cancer metastasis.
The research was conducted by a team comprised of researchers from the School of Arts and Sciences' Department of Biology; the Perelman School of Medicine's pathobiology and laboratory medicine, medicine and genetics departments, and China's Hangzhou Normal University School of Medicine.
![Cancer Prevention thro' Lifestyle Changes]( "Cancer Prevention thro' Lifestyle Changes")
Did u know that simple changes in lifestyle could lower your cancer risks? Find out how!
In the current work, they found that one form of Exo70 was associated with epithelial cells, which line the body's organs and cavities. They called this form Exo70E.
The fact that these forms associated with epithelial and mesenchymal cells, respectively, caused the researchers to think about a process called the epithelial-mesenchymal transition, or EMT. In it, epithelial cells, which are normally tightly packed together and structured, acquire the ability to migrate.
To see what role Exo70 might be playing in EMT, the researchers studied a laboratory cell line in which they could induce EMT. As the transition occurred, they observed that levels of Exo70E declined while Exo70M rose.
They found that a protein called epithelial splicing regulatory protein 1, or ESRP1, appeared to play a role in switching between forms, promoting the Exo70E form and preventing EMT from occurring.
The team found that adding Exo70E to mesenchymal cells caused them to look more like epithelial cells, retaining structure and inhibiting movement.
"We found that patients who had a high E-to-M form ratio had cancers that were less likely to have spread," senior author Wei Guo said. "Patients who had cancers that spread to the lymph nodes had more of the M form."
The study is published in the journal Developmental Cell.
Source: ANI
Cancer Prevention thro' Lifestyle Changes
Did u know that simple changes in lifestyle could lower your cancer risks? Find out how!
Advertisement
In the current work, they found that one form of Exo70 was associated with epithelial cells, which line the body's organs and cavities. They called this form Exo70E.
The fact that these forms associated with epithelial and mesenchymal cells, respectively, caused the researchers to think about a process called the epithelial-mesenchymal transition, or EMT. In it, epithelial cells, which are normally tightly packed together and structured, acquire the ability to migrate.
To see what role Exo70 might be playing in EMT, the researchers studied a laboratory cell line in which they could induce EMT. As the transition occurred, they observed that levels of Exo70E declined while Exo70M rose.
They found that a protein called epithelial splicing regulatory protein 1, or ESRP1, appeared to play a role in switching between forms, promoting the Exo70E form and preventing EMT from occurring.
The team found that adding Exo70E to mesenchymal cells caused them to look more like epithelial cells, retaining structure and inhibiting movement.
"We found that patients who had a high E-to-M form ratio had cancers that were less likely to have spread," senior author Wei Guo said. "Patients who had cancers that spread to the lymph nodes had more of the M form."
The study is published in the journal Developmental Cell.
Source: ANI
Women With HER2-positive Breast Cancer Benefited With Chemotherapy and Trastuzumab
Women with HER2-positive breast cancer who had the highest levels of immune cells in their tumors gained the most benefit from presurgery treatment with chemotherapy
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.
Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.
